Microbiome / Microbiota R&D and Business Collaboration Forum

San Diego, USA (Říjen, 2 - 3, 2014)

The 1 - 2 kilograms of bacteria living inside of, and on the surface of, all human beings -- the Human Microbiome -- constitutes both another "human" organ and a third protective "immune system" after the innate and adaptive immune systems.

Recent advances in understanding the influence of the Microbiome on human health have unequivocally demonstrated the substantive impact of microbiome dysbiosis on the etiology of dozens of human diseases and syndromes including Type-1 diabetes, refractory Clostridium difficile infections, ulcerative colitis, inflammatory bowel disease, Crohn's, necrotizing enterocolitis, celiac disease, asthma, pancreatic & colon cancers, childhood obesity, sinusitus and vaginosis, among many others.  As well, more disease associations are identified weekly in the literature.

Propitiously, the 5-year U.S. national Human Microbiome Project (HMP) was completed in June 2012, and all sequencing data was placed in the public domain, thereby offering a rich source of free information for basic research scientists, translational researchers, and biotech & pharma companies seeking new business opportunities.

Finally, the microbiome field uniquely offers a graduated spectrum of commercialization opportunities ranging from easy to hard, specifically:  consumer probiotics, FDA-regulated probiotics, microbiome transplants, selective bacterio-therapy, CLIA-based lab tests for microbiome-related conditions or diseases, microbiome supernatant treatments, individual and patentable compounds (drugs) isolated from specific microbiome bacteria, and chemistry- & receptor-based approaches to modify signaling of specific molecular targets in the gut.  In short, rarely has the biotechnology industry been offered such a cornucopia of R&D and business opportunities in one field.

This first-in-class, microbiome-focused hybrid R&D and business conference attracting 150 attendees from all over the world, plus a 40-strong speaker faculty, will provide an interactive networking forum to both further research and commercialization opportunities.  It also aims to answer your queries through a vibrant exhibition room full of technology providers showcasing their R&D platforms & services; as well as via scientific poster sessions; expert-led case-study presentations; and interactive Q&A panel discussions.

Více: http://www.globalengage.co.uk/microbiome.html